Möchten Sie immer auf dem neuesten Stand bleiben?

REDWOOD CITY, Calif., Jan. 06, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will offer high-performance enzymes for customers using...

REDWOOD CITY, Calif., Dec. 06, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, today announced that it has entered into an exclusive agreement with Tate...

REDWOOD CITY, Calif., Dec. 01, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that Bernard J. Kelley has been named Chairman of the Board,...

REDWOOD CITY, Calif., Nov. 10, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at the 7th Annual Craig-Hallum...

Revenues of $14.9 million driven by core biocatalyst product sales increase of 123%and include $8.0 million milestone revenue from Merck Conference call begins at 4:30 p.m. Eastern time today ...

REDWOOD CITY, Calif., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report third quarter 2016 financial results...

REDWOOD CITY, Calif., Oct. 17, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that Michael Aldridge has joined the company as Senior Vice...

REDWOOD CITY, Calif., Oct. 05, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announced the completion of the second and final phase in the transfer...

REDWOOD CITY, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at three upcoming investment...

Net income reaches $2.2 million; revenues of $16.0 million include milestone payments from GSK and a major biopharmaceutical company, and 62% growth in core biocatalyst product sales Conference...